nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2D6—breast cancer	0.146	0.538	CbGaD
Efavirenz—CYP3A4—breast cancer	0.125	0.462	CbGaD
Efavirenz—CYP2B6—Thiotepa—breast cancer	0.0376	0.0788	CbGbCtD
Efavirenz—CYP1A2—Anastrozole—breast cancer	0.0291	0.0609	CbGbCtD
Efavirenz—CYP1A2—Toremifene—breast cancer	0.0266	0.0557	CbGbCtD
Efavirenz—CYP2C9—Anastrozole—breast cancer	0.0262	0.0549	CbGbCtD
Efavirenz—CYP2B6—Raloxifene—breast cancer	0.0251	0.0526	CbGbCtD
Efavirenz—CYP2C19—Lapatinib—breast cancer	0.021	0.0441	CbGbCtD
Efavirenz—CYP3A4—Exemestane—breast cancer	0.0201	0.0421	CbGbCtD
Efavirenz—CYP2C9—Idarubicin—breast cancer	0.0198	0.0416	CbGbCtD
Efavirenz—CYP2D6—Idarubicin—breast cancer	0.0181	0.0381	CbGbCtD
Efavirenz—CYP3A4—Letrozole—breast cancer	0.0171	0.0358	CbGbCtD
Efavirenz—CYP2B6—Tamoxifen—breast cancer	0.0166	0.0347	CbGbCtD
Efavirenz—CYP3A4—Anastrozole—breast cancer	0.0152	0.0319	CbGbCtD
Efavirenz—CYP3A4—Toremifene—breast cancer	0.0139	0.0292	CbGbCtD
Efavirenz—CYP3A4—Fulvestrant—breast cancer	0.0129	0.0271	CbGbCtD
Efavirenz—CYP2B6—Irinotecan—breast cancer	0.0127	0.0267	CbGbCtD
Efavirenz—CYP3A4—Thiotepa—breast cancer	0.0115	0.0242	CbGbCtD
Efavirenz—CYP2C9—Capecitabine—breast cancer	0.0109	0.0228	CbGbCtD
Efavirenz—CYP3A4—Ixabepilone—breast cancer	0.0106	0.0221	CbGbCtD
Efavirenz—CYP2C19—Tamoxifen—breast cancer	0.0105	0.0221	CbGbCtD
Efavirenz—CYP3A4—Lapatinib—breast cancer	0.0102	0.0213	CbGbCtD
Efavirenz—CYP1A2—Tamoxifen—breast cancer	0.00971	0.0204	CbGbCtD
Efavirenz—CYP2D6—Vinorelbine—breast cancer	0.00886	0.0186	CbGbCtD
Efavirenz—CYP2C9—Tamoxifen—breast cancer	0.00875	0.0183	CbGbCtD
Efavirenz—CYP2D6—Tamoxifen—breast cancer	0.008	0.0168	CbGbCtD
Efavirenz—CYP3A4—Raloxifene—breast cancer	0.0077	0.0161	CbGbCtD
Efavirenz—CYP1A2—Fluorouracil—breast cancer	0.00716	0.015	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—breast cancer	0.00695	0.0146	CbGbCtD
Efavirenz—CYP2C9—Paclitaxel—breast cancer	0.00681	0.0143	CbGbCtD
Efavirenz—CYP2C9—Fluorouracil—breast cancer	0.00645	0.0135	CbGbCtD
Efavirenz—CYP3A4—Vinorelbine—breast cancer	0.00564	0.0118	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—breast cancer	0.00546	0.0115	CbGbCtD
Efavirenz—CYP3A4—Tamoxifen—breast cancer	0.00509	0.0107	CbGbCtD
Efavirenz—CYP3A4—Mitoxantrone—breast cancer	0.00496	0.0104	CbGbCtD
Efavirenz—CYP3A4—Paclitaxel—breast cancer	0.00396	0.0083	CbGbCtD
Efavirenz—CYP3A4—Irinotecan—breast cancer	0.00391	0.00819	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—breast cancer	0.00347	0.00728	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—breast cancer	0.00336	0.00704	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—breast cancer	0.00286	0.006	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—breast cancer	0.00213	0.00447	CbGbCtD
Efavirenz—Vomiting—Fluorouracil—breast cancer	2.87e-05	0.000149	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—breast cancer	2.87e-05	0.000149	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—breast cancer	2.87e-05	0.000149	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—breast cancer	2.86e-05	0.000148	CcSEcCtD
Efavirenz—Insomnia—Capecitabine—breast cancer	2.86e-05	0.000148	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—breast cancer	2.85e-05	0.000147	CcSEcCtD
Efavirenz—Rash—Fluorouracil—breast cancer	2.85e-05	0.000147	CcSEcCtD
Efavirenz—Dermatitis—Fluorouracil—breast cancer	2.85e-05	0.000147	CcSEcCtD
Efavirenz—Paraesthesia—Capecitabine—breast cancer	2.83e-05	0.000147	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—breast cancer	2.83e-05	0.000147	CcSEcCtD
Efavirenz—Hypersensitivity—Paclitaxel—breast cancer	2.83e-05	0.000147	CcSEcCtD
Efavirenz—Headache—Fluorouracil—breast cancer	2.83e-05	0.000146	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—breast cancer	2.83e-05	0.000146	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—breast cancer	2.82e-05	0.000146	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—breast cancer	2.82e-05	0.000146	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—breast cancer	2.82e-05	0.000146	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—breast cancer	2.81e-05	0.000146	CcSEcCtD
Efavirenz—Dyspnoea—Capecitabine—breast cancer	2.81e-05	0.000146	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—breast cancer	2.81e-05	0.000145	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—breast cancer	2.81e-05	0.000145	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—breast cancer	2.81e-05	0.000145	CcSEcCtD
Efavirenz—Nausea—Mitoxantrone—breast cancer	2.8e-05	0.000145	CcSEcCtD
Efavirenz—Nausea—Irinotecan—breast cancer	2.8e-05	0.000145	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—breast cancer	2.8e-05	0.000145	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—breast cancer	2.79e-05	0.000144	CcSEcCtD
Efavirenz—Pain—Docetaxel—breast cancer	2.79e-05	0.000144	CcSEcCtD
Efavirenz—Constipation—Docetaxel—breast cancer	2.79e-05	0.000144	CcSEcCtD
Efavirenz—Back pain—Methotrexate—breast cancer	2.79e-05	0.000144	CcSEcCtD
Efavirenz—Dyspepsia—Capecitabine—breast cancer	2.78e-05	0.000144	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—breast cancer	2.77e-05	0.000143	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—breast cancer	2.76e-05	0.000143	CcSEcCtD
Efavirenz—Asthenia—Paclitaxel—breast cancer	2.76e-05	0.000143	CcSEcCtD
Efavirenz—Decreased appetite—Capecitabine—breast cancer	2.74e-05	0.000142	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—breast cancer	2.74e-05	0.000142	CcSEcCtD
Efavirenz—Nausea—Gemcitabine—breast cancer	2.73e-05	0.000141	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Capecitabine—breast cancer	2.73e-05	0.000141	CcSEcCtD
Efavirenz—Fatigue—Capecitabine—breast cancer	2.72e-05	0.000141	CcSEcCtD
Efavirenz—Pruritus—Paclitaxel—breast cancer	2.72e-05	0.000141	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—breast cancer	2.71e-05	0.00014	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—breast cancer	2.71e-05	0.00014	CcSEcCtD
Efavirenz—Constipation—Capecitabine—breast cancer	2.7e-05	0.00014	CcSEcCtD
Efavirenz—Pain—Capecitabine—breast cancer	2.7e-05	0.00014	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—breast cancer	2.69e-05	0.000139	CcSEcCtD
Efavirenz—Erythema—Epirubicin—breast cancer	2.69e-05	0.000139	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—breast cancer	2.69e-05	0.000139	CcSEcCtD
Efavirenz—Nausea—Fluorouracil—breast cancer	2.68e-05	0.000139	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—breast cancer	2.68e-05	0.000139	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—breast cancer	2.67e-05	0.000138	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—breast cancer	2.67e-05	0.000138	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—breast cancer	2.67e-05	0.000138	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—breast cancer	2.66e-05	0.000138	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—breast cancer	2.66e-05	0.000138	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—breast cancer	2.66e-05	0.000138	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—breast cancer	2.66e-05	0.000137	CcSEcCtD
Efavirenz—Tension—Epirubicin—breast cancer	2.64e-05	0.000137	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—breast cancer	2.64e-05	0.000137	CcSEcCtD
Efavirenz—Diarrhoea—Paclitaxel—breast cancer	2.63e-05	0.000136	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—breast cancer	2.62e-05	0.000135	CcSEcCtD
Efavirenz—Back pain—Epirubicin—breast cancer	2.61e-05	0.000135	CcSEcCtD
Efavirenz—Feeling abnormal—Capecitabine—breast cancer	2.6e-05	0.000135	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—breast cancer	2.6e-05	0.000134	CcSEcCtD
Efavirenz—Malaise—Methotrexate—breast cancer	2.6e-05	0.000134	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—breast cancer	2.59e-05	0.000134	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—breast cancer	2.59e-05	0.000134	CcSEcCtD
Efavirenz—Gastrointestinal pain—Capecitabine—breast cancer	2.58e-05	0.000134	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—breast cancer	2.58e-05	0.000134	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—breast cancer	2.58e-05	0.000133	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—breast cancer	2.58e-05	0.000133	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—breast cancer	2.56e-05	0.000132	CcSEcCtD
Efavirenz—Dizziness—Paclitaxel—breast cancer	2.54e-05	0.000132	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—breast cancer	2.54e-05	0.000131	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—breast cancer	2.53e-05	0.000131	CcSEcCtD
Efavirenz—Cough—Methotrexate—breast cancer	2.51e-05	0.00013	CcSEcCtD
Efavirenz—Urticaria—Capecitabine—breast cancer	2.51e-05	0.00013	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—breast cancer	2.5e-05	0.000129	CcSEcCtD
Efavirenz—Abdominal pain—Capecitabine—breast cancer	2.5e-05	0.000129	CcSEcCtD
Efavirenz—Body temperature increased—Capecitabine—breast cancer	2.5e-05	0.000129	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—breast cancer	2.49e-05	0.000129	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—breast cancer	2.49e-05	0.000129	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—breast cancer	2.49e-05	0.000129	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—breast cancer	2.49e-05	0.000129	CcSEcCtD
Efavirenz—Agitation—Epirubicin—breast cancer	2.48e-05	0.000128	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—breast cancer	2.46e-05	0.000127	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—breast cancer	2.45e-05	0.000127	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—breast cancer	2.45e-05	0.000127	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—breast cancer	2.45e-05	0.000127	CcSEcCtD
Efavirenz—Tension—Doxorubicin—breast cancer	2.45e-05	0.000127	CcSEcCtD
Efavirenz—Vomiting—Paclitaxel—breast cancer	2.45e-05	0.000127	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—breast cancer	2.44e-05	0.000126	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.43e-05	0.000126	CcSEcCtD
Efavirenz—Malaise—Epirubicin—breast cancer	2.43e-05	0.000126	CcSEcCtD
Efavirenz—Rash—Paclitaxel—breast cancer	2.43e-05	0.000126	CcSEcCtD
Efavirenz—Dermatitis—Paclitaxel—breast cancer	2.42e-05	0.000125	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—breast cancer	2.42e-05	0.000125	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—breast cancer	2.42e-05	0.000125	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—breast cancer	2.42e-05	0.000125	CcSEcCtD
Efavirenz—Syncope—Epirubicin—breast cancer	2.42e-05	0.000125	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—breast cancer	2.41e-05	0.000125	CcSEcCtD
Efavirenz—Headache—Paclitaxel—breast cancer	2.41e-05	0.000125	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—breast cancer	2.4e-05	0.000124	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—breast cancer	2.38e-05	0.000123	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—breast cancer	2.37e-05	0.000123	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—breast cancer	2.37e-05	0.000123	CcSEcCtD
Efavirenz—Cough—Epirubicin—breast cancer	2.35e-05	0.000122	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—breast cancer	2.35e-05	0.000122	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—breast cancer	2.34e-05	0.000121	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—breast cancer	2.33e-05	0.000121	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—breast cancer	2.33e-05	0.00012	CcSEcCtD
Efavirenz—Hypersensitivity—Capecitabine—breast cancer	2.33e-05	0.00012	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—breast cancer	2.31e-05	0.00012	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—breast cancer	2.31e-05	0.000119	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—breast cancer	2.3e-05	0.000119	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—breast cancer	2.3e-05	0.000119	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—breast cancer	2.3e-05	0.000119	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—breast cancer	2.29e-05	0.000119	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—breast cancer	2.29e-05	0.000119	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—breast cancer	2.29e-05	0.000119	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—breast cancer	2.29e-05	0.000119	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—breast cancer	2.29e-05	0.000118	CcSEcCtD
Efavirenz—Nausea—Paclitaxel—breast cancer	2.29e-05	0.000118	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—breast cancer	2.28e-05	0.000118	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.28e-05	0.000118	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—breast cancer	2.27e-05	0.000118	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—breast cancer	2.27e-05	0.000117	CcSEcCtD
Efavirenz—Asthenia—Capecitabine—breast cancer	2.27e-05	0.000117	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—breast cancer	2.25e-05	0.000116	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—breast cancer	2.24e-05	0.000116	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—breast cancer	2.24e-05	0.000116	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—breast cancer	2.24e-05	0.000116	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—breast cancer	2.24e-05	0.000116	CcSEcCtD
Efavirenz—Pruritus—Capecitabine—breast cancer	2.23e-05	0.000116	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—breast cancer	2.23e-05	0.000115	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—breast cancer	2.22e-05	0.000115	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—breast cancer	2.2e-05	0.000114	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—breast cancer	2.19e-05	0.000113	CcSEcCtD
Efavirenz—Cough—Doxorubicin—breast cancer	2.18e-05	0.000113	CcSEcCtD
Efavirenz—Shock—Epirubicin—breast cancer	2.16e-05	0.000112	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—breast cancer	2.16e-05	0.000112	CcSEcCtD
Efavirenz—Diarrhoea—Capecitabine—breast cancer	2.16e-05	0.000112	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—breast cancer	2.16e-05	0.000112	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—breast cancer	2.16e-05	0.000112	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—breast cancer	2.15e-05	0.000111	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—breast cancer	2.15e-05	0.000111	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—breast cancer	2.15e-05	0.000111	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—breast cancer	2.14e-05	0.000111	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—breast cancer	2.14e-05	0.000111	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—breast cancer	2.13e-05	0.00011	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—breast cancer	2.13e-05	0.00011	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—breast cancer	2.12e-05	0.00011	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—breast cancer	2.12e-05	0.00011	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—breast cancer	2.12e-05	0.00011	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—breast cancer	2.12e-05	0.000109	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—breast cancer	2.11e-05	0.000109	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.11e-05	0.000109	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—breast cancer	2.1e-05	0.000109	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—breast cancer	2.1e-05	0.000108	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—breast cancer	2.1e-05	0.000108	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—breast cancer	2.09e-05	0.000108	CcSEcCtD
Efavirenz—Dizziness—Capecitabine—breast cancer	2.09e-05	0.000108	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—breast cancer	2.08e-05	0.000107	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—breast cancer	2.07e-05	0.000107	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—breast cancer	2.07e-05	0.000107	CcSEcCtD
Efavirenz—Rash—Docetaxel—breast cancer	2.06e-05	0.000106	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—breast cancer	2.05e-05	0.000106	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—breast cancer	2.05e-05	0.000106	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—breast cancer	2.04e-05	0.000106	CcSEcCtD
Efavirenz—Headache—Docetaxel—breast cancer	2.04e-05	0.000106	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—breast cancer	2.03e-05	0.000105	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—breast cancer	2.03e-05	0.000105	CcSEcCtD
Efavirenz—Pain—Methotrexate—breast cancer	2.01e-05	0.000104	CcSEcCtD
Efavirenz—Vomiting—Capecitabine—breast cancer	2.01e-05	0.000104	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—breast cancer	2e-05	0.000104	CcSEcCtD
Efavirenz—Shock—Doxorubicin—breast cancer	2e-05	0.000104	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—breast cancer	1.99e-05	0.000103	CcSEcCtD
Efavirenz—Rash—Capecitabine—breast cancer	1.99e-05	0.000103	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—breast cancer	1.99e-05	0.000103	CcSEcCtD
Efavirenz—Dermatitis—Capecitabine—breast cancer	1.99e-05	0.000103	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—breast cancer	1.99e-05	0.000103	CcSEcCtD
Efavirenz—Headache—Capecitabine—breast cancer	1.98e-05	0.000102	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—breast cancer	1.98e-05	0.000102	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—breast cancer	1.97e-05	0.000102	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—breast cancer	1.97e-05	0.000102	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—breast cancer	1.96e-05	0.000101	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—breast cancer	1.96e-05	0.000101	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—breast cancer	1.94e-05	0.0001	CcSEcCtD
Efavirenz—Nausea—Docetaxel—breast cancer	1.94e-05	0.0001	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—breast cancer	1.94e-05	0.0001	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—breast cancer	1.94e-05	0.0001	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—breast cancer	1.92e-05	9.94e-05	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—breast cancer	1.91e-05	9.89e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—breast cancer	1.9e-05	9.82e-05	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—breast cancer	1.9e-05	9.81e-05	CcSEcCtD
Efavirenz—Pain—Epirubicin—breast cancer	1.88e-05	9.73e-05	CcSEcCtD
Efavirenz—Constipation—Epirubicin—breast cancer	1.88e-05	9.73e-05	CcSEcCtD
Efavirenz—Nausea—Capecitabine—breast cancer	1.88e-05	9.7e-05	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—breast cancer	1.87e-05	9.66e-05	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—breast cancer	1.86e-05	9.61e-05	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—breast cancer	1.86e-05	9.61e-05	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.85e-05	9.59e-05	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—breast cancer	1.84e-05	9.52e-05	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—breast cancer	1.83e-05	9.45e-05	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—breast cancer	1.81e-05	9.39e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—breast cancer	1.81e-05	9.38e-05	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—breast cancer	1.81e-05	9.36e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—breast cancer	1.8e-05	9.31e-05	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—breast cancer	1.79e-05	9.27e-05	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—breast cancer	1.77e-05	9.15e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—breast cancer	1.76e-05	9.09e-05	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—breast cancer	1.75e-05	9.08e-05	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—breast cancer	1.75e-05	9.04e-05	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—breast cancer	1.74e-05	9e-05	CcSEcCtD
Efavirenz—Pain—Doxorubicin—breast cancer	1.74e-05	9e-05	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—breast cancer	1.74e-05	9e-05	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—breast cancer	1.74e-05	9e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—breast cancer	1.73e-05	8.96e-05	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—breast cancer	1.69e-05	8.72e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—breast cancer	1.68e-05	8.68e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—breast cancer	1.66e-05	8.61e-05	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—breast cancer	1.66e-05	8.6e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—breast cancer	1.62e-05	8.38e-05	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—breast cancer	1.62e-05	8.36e-05	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—breast cancer	1.61e-05	8.32e-05	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—breast cancer	1.61e-05	8.32e-05	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—breast cancer	1.61e-05	8.32e-05	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—breast cancer	1.58e-05	8.16e-05	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—breast cancer	1.56e-05	8.05e-05	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—breast cancer	1.55e-05	8.04e-05	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—breast cancer	1.5e-05	7.79e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—breast cancer	1.5e-05	7.76e-05	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—breast cancer	1.49e-05	7.73e-05	CcSEcCtD
Efavirenz—Rash—Methotrexate—breast cancer	1.48e-05	7.67e-05	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—breast cancer	1.48e-05	7.66e-05	CcSEcCtD
Efavirenz—Headache—Methotrexate—breast cancer	1.47e-05	7.62e-05	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—breast cancer	1.46e-05	7.55e-05	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—breast cancer	1.45e-05	7.53e-05	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—breast cancer	1.44e-05	7.45e-05	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—breast cancer	1.4e-05	7.24e-05	CcSEcCtD
Efavirenz—Nausea—Methotrexate—breast cancer	1.4e-05	7.22e-05	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—breast cancer	1.39e-05	7.2e-05	CcSEcCtD
Efavirenz—Rash—Epirubicin—breast cancer	1.39e-05	7.18e-05	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—breast cancer	1.39e-05	7.17e-05	CcSEcCtD
Efavirenz—Headache—Epirubicin—breast cancer	1.38e-05	7.13e-05	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—breast cancer	1.35e-05	6.96e-05	CcSEcCtD
Efavirenz—Nausea—Epirubicin—breast cancer	1.31e-05	6.76e-05	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—breast cancer	1.29e-05	6.69e-05	CcSEcCtD
Efavirenz—Rash—Doxorubicin—breast cancer	1.28e-05	6.64e-05	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—breast cancer	1.28e-05	6.63e-05	CcSEcCtD
Efavirenz—Headache—Doxorubicin—breast cancer	1.27e-05	6.6e-05	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—breast cancer	1.21e-05	6.25e-05	CcSEcCtD
Efavirenz—CYP2C9—Metabolism—CYP17A1—breast cancer	5.31e-06	9.15e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO1—breast cancer	5.3e-06	9.13e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS1—breast cancer	5.3e-06	9.13e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A5—breast cancer	5.29e-06	9.12e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO1—breast cancer	5.25e-06	9.05e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS1—breast cancer	5.25e-06	9.05e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TYMS—breast cancer	5.24e-06	9.04e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.23e-06	9.02e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLA2G4A—breast cancer	5.18e-06	8.93e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NCOR1—breast cancer	5.18e-06	8.93e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—breast cancer	5.18e-06	8.93e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA3—breast cancer	5.18e-06	8.92e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.17e-06	8.91e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2D6—breast cancer	5.15e-06	8.88e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A2—breast cancer	5.14e-06	8.86e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA9—breast cancer	5.13e-06	8.84e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA4—breast cancer	5.13e-06	8.84e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC2A1—breast cancer	5.11e-06	8.81e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NQO1—breast cancer	5.11e-06	8.81e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA2—breast cancer	5.1e-06	8.79e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.09e-06	8.77e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA2—breast cancer	5.06e-06	8.72e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CPT1A—breast cancer	5.04e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTR—breast cancer	5.04e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCG2—breast cancer	5.04e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5e-06	8.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX2—breast cancer	5e-06	8.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA2—breast cancer	5e-06	8.62e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP3A4—breast cancer	4.98e-06	8.59e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—breast cancer	4.96e-06	8.55e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.96e-06	8.54e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—FASN—breast cancer	4.95e-06	8.53e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HPGDS—breast cancer	4.94e-06	8.51e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX4—breast cancer	4.94e-06	8.51e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SULT1A1—breast cancer	4.94e-06	8.51e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BCHE—breast cancer	4.93e-06	8.49e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—breast cancer	4.91e-06	8.47e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HBA1—breast cancer	4.91e-06	8.46e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—FASN—breast cancer	4.9e-06	8.45e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1B1—breast cancer	4.9e-06	8.44e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BCHE—breast cancer	4.88e-06	8.42e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ERCC2—breast cancer	4.87e-06	8.4e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A5—breast cancer	4.87e-06	8.39e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A5—breast cancer	4.82e-06	8.31e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA1—breast cancer	4.82e-06	8.31e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH1—breast cancer	4.82e-06	8.31e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.8e-06	8.28e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—breast cancer	4.79e-06	8.26e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACHE—breast cancer	4.79e-06	8.26e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAT2—breast cancer	4.77e-06	8.22e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC2A1—breast cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NQO1—breast cancer	4.7e-06	8.1e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOA1—breast cancer	4.67e-06	8.05e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NQO1—breast cancer	4.66e-06	8.03e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC2A1—breast cancer	4.66e-06	8.03e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—STK11—breast cancer	4.61e-06	7.94e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP19A1—breast cancer	4.61e-06	7.94e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP3A4—breast cancer	4.58e-06	7.9e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—breast cancer	4.58e-06	7.89e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.56e-06	7.86e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP3A4—breast cancer	4.54e-06	7.83e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP17A1—breast cancer	4.54e-06	7.82e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.52e-06	7.79e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1B1—breast cancer	4.51e-06	7.77e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS1—breast cancer	4.49e-06	7.74e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO1—breast cancer	4.49e-06	7.74e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.47e-06	7.71e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1B1—breast cancer	4.47e-06	7.7e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.42e-06	7.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.42e-06	7.61e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2D6—breast cancer	4.4e-06	7.59e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HSP90AA1—breast cancer	4.38e-06	7.55e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.32e-06	7.45e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA2—breast cancer	4.32e-06	7.45e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA1—breast cancer	4.3e-06	7.41e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—COMT—breast cancer	4.28e-06	7.38e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—breast cancer	4.26e-06	7.35e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA1—breast cancer	4.26e-06	7.34e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—STK11—breast cancer	4.24e-06	7.3e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP19A1—breast cancer	4.24e-06	7.3e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAV1—breast cancer	4.23e-06	7.28e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—breast cancer	4.2e-06	7.24e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—STK11—breast cancer	4.2e-06	7.24e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP19A1—breast cancer	4.2e-06	7.24e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ITPR1—breast cancer	4.19e-06	7.23e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—FASN—breast cancer	4.19e-06	7.22e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—DPYD—breast cancer	4.18e-06	7.21e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MED12—breast cancer	4.18e-06	7.21e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BCHE—breast cancer	4.17e-06	7.19e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A5—breast cancer	4.12e-06	7.11e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOA—breast cancer	4.12e-06	7.09e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—breast cancer	4.03e-06	6.95e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA3—breast cancer	4e-06	6.89e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NQO1—breast cancer	3.98e-06	6.86e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A1—breast cancer	3.98e-06	6.86e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A2—breast cancer	3.97e-06	6.84e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TYMS—breast cancer	3.96e-06	6.83e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.94e-06	6.79e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—COMT—breast cancer	3.94e-06	6.79e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—breast cancer	3.92e-06	6.76e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOR1—breast cancer	3.92e-06	6.75e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.92e-06	6.75e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—breast cancer	3.92e-06	6.75e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—COMT—breast cancer	3.9e-06	6.73e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.9e-06	6.72e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTR—breast cancer	3.89e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG2—breast cancer	3.89e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CPT1A—breast cancer	3.89e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—breast cancer	3.89e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP3A4—breast cancer	3.88e-06	6.69e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—breast cancer	3.87e-06	6.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.86e-06	6.66e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ITPR1—breast cancer	3.86e-06	6.65e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—breast cancer	3.85e-06	6.63e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—breast cancer	3.83e-06	6.61e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ITPR1—breast cancer	3.82e-06	6.59e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1B1—breast cancer	3.82e-06	6.58e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HPGDS—breast cancer	3.81e-06	6.57e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HBA1—breast cancer	3.79e-06	6.53e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—breast cancer	3.75e-06	6.46e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.74e-06	6.45e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—breast cancer	3.71e-06	6.4e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—breast cancer	3.71e-06	6.4e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—breast cancer	3.7e-06	6.37e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACHE—breast cancer	3.7e-06	6.37e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ERCC2—breast cancer	3.68e-06	6.35e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—breast cancer	3.68e-06	6.34e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TYMS—breast cancer	3.64e-06	6.28e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA1—breast cancer	3.64e-06	6.28e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TYMS—breast cancer	3.61e-06	6.23e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOR1—breast cancer	3.6e-06	6.21e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.6e-06	6.21e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—breast cancer	3.6e-06	6.21e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—STK11—breast cancer	3.59e-06	6.19e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP19A1—breast cancer	3.59e-06	6.19e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOR1—breast cancer	3.57e-06	6.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.57e-06	6.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—breast cancer	3.57e-06	6.15e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP17A1—breast cancer	3.5e-06	6.03e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO1—breast cancer	3.46e-06	5.97e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS1—breast cancer	3.46e-06	5.97e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—breast cancer	3.46e-06	5.97e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—breast cancer	3.45e-06	5.95e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—breast cancer	3.42e-06	5.89e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—breast cancer	3.42e-06	5.89e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2D6—breast cancer	3.4e-06	5.86e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ERCC2—breast cancer	3.39e-06	5.84e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—breast cancer	3.39e-06	5.83e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—breast cancer	3.38e-06	5.83e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.37e-06	5.81e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ERCC2—breast cancer	3.36e-06	5.79e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—breast cancer	3.34e-06	5.76e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—COMT—breast cancer	3.34e-06	5.75e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA2—breast cancer	3.34e-06	5.75e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—breast cancer	3.32e-06	5.72e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—breast cancer	3.28e-06	5.64e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ITPR1—breast cancer	3.27e-06	5.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FASN—breast cancer	3.23e-06	5.57e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BCHE—breast cancer	3.22e-06	5.55e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—breast cancer	3.19e-06	5.51e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAV1—breast cancer	3.19e-06	5.5e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—breast cancer	3.18e-06	5.49e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A5—breast cancer	3.18e-06	5.48e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—breast cancer	3.16e-06	5.44e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—breast cancer	3.14e-06	5.42e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TYMS—breast cancer	3.09e-06	5.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A1—breast cancer	3.07e-06	5.3e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NQO1—breast cancer	3.07e-06	5.3e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOR1—breast cancer	3.05e-06	5.26e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.05e-06	5.26e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—breast cancer	3.05e-06	5.26e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.05e-06	5.26e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—breast cancer	2.95e-06	5.08e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1B1—breast cancer	2.95e-06	5.08e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAV1—breast cancer	2.94e-06	5.06e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—breast cancer	2.92e-06	5.04e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—breast cancer	2.92e-06	5.04e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAV1—breast cancer	2.91e-06	5.02e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—breast cancer	2.91e-06	5.01e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—breast cancer	2.89e-06	4.99e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.89e-06	4.98e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ERCC2—breast cancer	2.87e-06	4.95e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA1—breast cancer	2.81e-06	4.84e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.78e-06	4.79e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—STK11—breast cancer	2.77e-06	4.77e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP19A1—breast cancer	2.77e-06	4.77e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—breast cancer	2.7e-06	4.65e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—breast cancer	2.67e-06	4.61e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—breast cancer	2.65e-06	4.57e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—COMT—breast cancer	2.58e-06	4.44e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—breast cancer	2.56e-06	4.42e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—breast cancer	2.56e-06	4.41e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—breast cancer	2.55e-06	4.39e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—breast cancer	2.53e-06	4.36e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—breast cancer	2.52e-06	4.35e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ITPR1—breast cancer	2.52e-06	4.35e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAV1—breast cancer	2.49e-06	4.29e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—breast cancer	2.43e-06	4.18e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—breast cancer	2.41e-06	4.16e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TYMS—breast cancer	2.38e-06	4.11e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.38e-06	4.1e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—breast cancer	2.36e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOR1—breast cancer	2.36e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.36e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—breast cancer	2.35e-06	4.05e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—breast cancer	2.33e-06	4.02e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—breast cancer	2.32e-06	4e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—breast cancer	2.3e-06	3.97e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—breast cancer	2.27e-06	3.91e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—breast cancer	2.26e-06	3.89e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—breast cancer	2.23e-06	3.85e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—breast cancer	2.23e-06	3.84e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—breast cancer	2.22e-06	3.83e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ERCC2—breast cancer	2.21e-06	3.82e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—breast cancer	2.21e-06	3.81e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—breast cancer	2.2e-06	3.79e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—breast cancer	2.08e-06	3.59e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—breast cancer	2.05e-06	3.53e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—breast cancer	2.03e-06	3.5e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—breast cancer	2.03e-06	3.5e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—breast cancer	2.01e-06	3.47e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—breast cancer	1.99e-06	3.43e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—breast cancer	1.97e-06	3.39e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—breast cancer	1.93e-06	3.32e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAV1—breast cancer	1.92e-06	3.31e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—breast cancer	1.88e-06	3.24e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—breast cancer	1.8e-06	3.1e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—breast cancer	1.77e-06	3.05e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—breast cancer	1.76e-06	3.03e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—breast cancer	1.75e-06	3.01e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—breast cancer	1.74e-06	2.99e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—breast cancer	1.72e-06	2.97e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—breast cancer	1.54e-06	2.65e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—breast cancer	1.52e-06	2.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—breast cancer	1.5e-06	2.59e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—breast cancer	1.47e-06	2.53e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—breast cancer	1.45e-06	2.5e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—breast cancer	1.36e-06	2.34e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—breast cancer	1.34e-06	2.31e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—breast cancer	1.33e-06	2.29e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—breast cancer	1.25e-06	2.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—breast cancer	1.24e-06	2.13e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—breast cancer	1.16e-06	2e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—breast cancer	1.11e-06	1.91e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—breast cancer	1.06e-06	1.82e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—breast cancer	1.02e-06	1.76e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—breast cancer	1.01e-06	1.74e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—breast cancer	8.65e-07	1.49e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—breast cancer	8.17e-07	1.41e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—breast cancer	6.67e-07	1.15e-05	CbGpPWpGaD
